Chronic proton pump inhibitor therapy and the risk of colorectal cancer
about
Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposisProton pump inhibitors and risk of periampullary cancers--A nested case-control studyLong-term proton pump inhibitor use and gastrointestinal cancerNon-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study.Adverse effects of long-term proton pump inhibitor therapy.Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies.Proton pump inhibitors: Risks of long-term use.Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus.Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control studyHypergastrinemiaAtrophic gastritis and the risk of incident colorectal cancer.Colorectal cancer risk in relation to use of acid suppressive medications.Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.Acid peptic diseases: pharmacological approach to treatment.Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?Indications and safety of proton pump inhibitor drug use in patients with cancer.Proton pump inhibitors and the risk of colorectal cancer.Paradoxically augmented anti-tumorigenic action of proton pump inhibitor and GastrininAPCMin/+ intestinal polyposis model.Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects.Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors.Proton pump inhibitors on pancreatic cancer risk and survival.Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study.Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.Medical Record Databases
P2860
Q24648651-2A816404-B78F-4EED-BA8A-B3497571D9D7Q28385784-0F514594-D7F4-4DF3-B2FA-03163EEE8B58Q33727006-C7952999-BD89-433B-B1E2-72AE94ED18E8Q33834355-2A272119-EDB7-4D2D-8687-F8BA3757B4AFQ34167899-F064231F-571A-444A-B4DB-76EAC3917E45Q34463547-7845706B-A56E-4C1F-91D7-9576EF5BF28DQ34549406-5990297F-AC1C-4694-BB94-67377B5CEE8CQ35116562-2A46E50B-D1CC-4114-890E-B888DE28DA22Q35653793-0815D2FF-1A80-48D1-B3FD-13B9A9F71555Q35923382-F7803EE4-5BE0-4FE3-89F0-2CD7A9324711Q36434231-74502253-F924-45ED-BCD2-CF77225FF620Q36949692-3B454007-48F4-460F-BB6C-8FE890024320Q37222668-EC877F6C-C335-46C6-A63E-C3643B778F79Q37524960-BFF89954-FE84-4187-B37A-364CF9070075Q37634491-4833F689-80C6-49D1-9C60-E66104D25BF6Q37913063-1BF0F1AB-6040-4180-B548-F8629C200FF4Q38011261-E31FBCF4-EC25-4EC0-A5E7-9E0D6E05321BQ38104388-98EE958B-0BE7-4478-84F3-8B3A41853940Q38459132-59E942E0-ED0F-4503-ABC7-7C8AABC4F81BQ39021463-C71F6C96-46FC-4C59-A2B7-BD628965E7E3Q41146448-F0D851CB-8FEB-4756-8E76-F0773BCDFF11Q46076164-B16C5C4D-55E2-4A66-934E-0EB49C21CEFEQ47350333-7CB54A28-B071-4A94-8171-E247F8F493DDQ50206074-E55B4D89-E8F7-4561-881D-8573C5850FC0Q50970848-28F51293-C36A-4560-AE15-F65A34E1953DQ53059964-5C86C70B-A17E-498D-8727-205D003154B1Q55493690-BB3A4656-3278-49F5-88F9-0C57C55F110DQ57299690-4F69FE8F-38A6-4D57-90B4-47E9429AC85A
P2860
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@ast
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@en
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@nl
type
label
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@ast
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@en
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@nl
prefLabel
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@ast
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@en
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@nl
P2093
P1433
P1476
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
@en
P2093
Alireza Sedarat
James D Lewis
Kathleen Propert
Sean Hennessy
Wei-Ting Hwang
Yu-Xiao Yang
P304
P356
10.1053/J.GASTRO.2007.06.022
P407
P577
2007-09-01T00:00:00Z